Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

Sarepta Therapeutics said it received approval from the Food & Drug Administration to update prescribing information for Elevidys, its gene therapy for Duchenne muscular dystrophy.

The UN-endorsed 2030 Agenda for Sustainable Development presents a shared roadmap for peace and prosperity for people today, ...

As the global population grows, producing enough food for everyone has become one of the biggest challenges in agriculture.

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

Humans have been shaping life for thousands of years through farming, breeding, and selective cultivation. But with modern tools like CRISPR, we can now directly edit DNA itself—rewriting the very ...

Life sciences revolve around many living forms such as humans, plants, animals, and microorganisms. The discoveries made ...

Spicy food, a chemical pain disguised as flavor, triggers our body's emergency response. Yet, humans embrace this discomfort, ...

Researchers have developed a synthetic regeneration system for genetically editing crops, avoiding the challenging step of ...

In a state famous for its endless horizons and agricultural prowess, Lauritzen Gardens stands as Omaha’s lush rebellion against the stereotype that Nebraska is just one giant cornfield with a football ...